|
Aakash Exploration
|
|
|
|
Aakash Exploration Services Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
|
|
|
Abhishek Integration
|
|
|
|
Abhishek Integrations Limited has informed the Exchange regarding 'Company does not fall under Large Corporate Category'.
|
|
|
Abhishek Integration
|
|
|
|
Abhishek Integrations Limited has informed the Exchange regarding 'received Letter of Intent (L.O.I.) for the wok of Supply of Spares for GLF Installations at M.B.B. Airport Agartala having total contract value of Rs. 98.15 Lakhs (including GST).'.
|
|
|
Abhishek Integration
|
|
|
|
Abhishek Integrations Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
|
|
|
Accent Microcell
|
|
|
|
Accent Microcell Limited has informed the Exchange regarding Outcome of Board Meeting held on May 12, 2026.
|
|
|
Apex Ecotech
|
|
|
|
Apex Ecotech Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on May 12, 2026
|
|
|
Apollo Ingredients
|
|
|
|
Audited Results Inter alia, to consider and approve:- 1. To consider and approve the resignation of Mr. James Mody (DIN: 08072328) from the position of Non-Executive Director of the Company. 2. To consider and approve the appointment of Mr. Amol Nirungkar as Independent Director of the Company. 3. To consider and approve the change in designation of Ms. Lovely Ghanshyam Mutreja (DIN: 03307922) from the position of Managing Director of the Company to Executive director (Marketing Director) of the Company on such terms and conditions, including payment of commission not exceeding 2% of sales in lieu of salary. 4. To consider and approve the change in designation of Mr. Kirit Ghanshyam Mutreja (DIN: 07514391) from Executive Director to Managing Director of the Company, on such terms and conditions as may be determined by the Board. 5. Any other matter with the permission of the Chair.
|
|
|
Avi Products India
|
|
|
|
Mark Corporate Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Offer Opening Public Announcement under Regulation 18(7) of Securities and Exchange Board of India (Substantial Acquistion of Shares and Takeovers) Regulations, 2011 as amended for the attention of the eligible Equity Shareholders of Avi Products India Ltd ("Target Company").
|
|
|
Balaxi Pharma.
|
|
|
|
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding 'RTA Report for Re-lodgement of Transfer Requests of Physical Shares for the period ended April 2026'.
|
|
|
Black Box
|
|
|
|
Please find enclosed herewith clarification letter sought by the exchange.
|
|
|
|
|
|